The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Open accessAbstract
BACKGROUND: Hypertension is common in autosomal dominant polycystic kidney disease (ADPKD) and is associated with increased total kidney volume, activation of the renin-angiotensin-aldosterone system, and progression of kidney disease. METHODS: In this double-blind, placebo-controlled trial, we randomly assigned 558 hypertensive participants with ADPKD (15 to 49 years of age, with an estimated glomerular filtration rate [GFR] >60 ml per minute per 1.73 m(2) of body-surface area) to either a standard blood-pressure target (120/70 to 130/80 mm Hg) or a low blood-pressure target (95/60 to 110/75 mm Hg) and to either an angiotensin-converting-enzyme inhibitor (lisinopril) plus an angiotensin-receptor blocker (telmisartan) or lisinopril plus placebo. The primary outcome was the annual percentage change in the total kidney volume. RESULTS: The annual percentage increase in total kidney volume was significantly lower in the low-blood-pressure group than in the standard-blood-pressure group (5.6% vs. 6.6%, P=0.006), without significant differences between the lisinopril-telmisartan group and the lisinopril-placebo group. The rate of change in estimated GFR was similar in the two medication groups, with a negative slope difference in the short term in the low-blood-pressure group as compared with the standard-blood-pressure group (P<0.001) and a marginally positive slope difference in the long term (P=0.05). The left-ventricular-mass index decreased more in the low-blood-pressure group than in the standard-blood-pressure group (-1.17 vs. -0.57 g per square meter per year, P<0.001); urinary albumin excretion was reduced by 3.77% with the low-pressure target and increased by 2.43% with the standard target (P<0.001). Dizziness and light-headedness were more common in the low-blood-pressure group than in the standard-blood-pressure group (80.7% vs. 69.4%, P=0.002). CONCLUSIONS: In early ADPKD, the combination of lisinopril and telmisartan did not significantly alter the rate of increase in total kidney volume. As compared with standard blood-pressure control, rigorous blood-pressure control was associated with a slower increase in total kidney volume, no overall change in the estimated GFR, a greater decline in the left-ventricular-mass index, and greater reduction in urinary albumin excretion. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; HALT-PKD [Study A] ClinicalTrials.gov number, NCT00283686.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
On the regression analysis of multivariate failure time data
PRENTICE, R. L., WILLIAMS, B. J., & PETERSON, A. V. (1981) · Biometrika · doi:10.1093/biomet/68.2.373 · Cited by 1,333
Matsushita, K., Mahmoodi, B. K., Woodward, M., Emberson, J. R., Jafar, T. H., Jee, S. H., Polkinghorne, K. R., Shankar, A., Smith, D. H., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.3954 · Cited by 988
Volume Progression in Polycystic Kidney Disease
Grantham, J. J., Torres, V. E., Chapman, A. B., Guay-Woodford, L. M., Bae, K. T., King, B. F., Wetzel, L. H., Baumgarten, D. A., Kenney, P. J., Harris, P. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054341 · Cited by 807
Self-citationAutosomal dominant polycystic kidney disease: the last 3 years
Torres, V. E., & Harris, P. C. (2009) · Kidney International · doi:10.1038/ki.2009.128 · Cited by 590
Self-citationAutosomal Dominant Polycystic Kidney Disease
Grantham, J. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0804458 · Cited by 543
Self-citationFactors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Gabow, P. A., Johnson, A. M., Kaehny, W. D., Kimberling, W. J., Lezotte, D. C., Duley, I. T., & Jones, R. H. (1992) · Kidney International · doi:10.1038/ki.1992.195 · Cited by 509
The Renin–Angiotensin–Aldosterone System and Autosomal Dominant Polycystic Kidney Disease
Chapman, A. B., Johnson, A., Gabow, P. A., & Schrier, R. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231602 · Cited by 398
Self-citationKidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
Chapman, A. B., Bost, J. E., Torres, V. E., Guay-Woodford, L., Bae, K. T., Landsittel, D., Li, J., King, B. F., Martin, D., Wetzel, L. H., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09500911 · Cited by 378
Self-citationGrantham, J. J., Chapman, A. B., & Torres, V. E. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00330705 · Cited by 278
Self-citationKlahr, S., Breyer, J. A., Beck, G. J., Dennis, V. W., Hartman, J. A., Roth, D., Steinman, T. I., Wang, S. R., & Yamamoto, M. E. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122037 · Cited by 251
Self-citationMakani, H., Bangalore, S., Desouza, K. A., Shah, A., & Messerli, F. H. (2013) · BMJ · doi:10.1136/bmj.f360 · Cited by 244
Renal structure and hypertension in autosomal dominant polycystic kidney disease
Gabow, P. A., Chapman, A. B., Johnson, A. M., Tangel, D. J., Duley, I. T., Kaehny, W. D., Manco-Johnson, M., & Schrier, R. W. (1990) · Kidney International · doi:10.1038/ki.1990.330 · Cited by 225
Self-citationBlood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study
Kovesdy, C. P., Bleyer, A. J., Molnar, M. Z., Ma, J. Z., Sim, J. J., Cushman, W. C., Quarles, L. D., & Kalantar-Zadeh, K. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-4-201308200-00004 · Cited by 213
Schrier, R., McFann, K., Johnson, A., Chapman, A., Edelstein, C., Brosnahan, G., Ecder, T., & Tison, L. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018407.60002.b9 · Cited by 200
Self-citationPredictors of Autosomal Dominant Polycystic Kidney Disease Progression
Schrier, R. W., Brosnahan, G., Cadnapaphornchai, M. A., Chonchol, M., Friend, K., Gitomer, B., & Rossetti, S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111184 · Cited by 171
Self-citationThe HALT Polycystic Kidney Disease Trials: Design and Implementation
Chapman, A. B., Torres, V. E., Perrone, R. D., Steinman, T. I., Bae, K. T., Miller, J. P., Miskulin, D. C., Rahbari-Oskoui, F. F., Masoumi, A., Hogan, M. C., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04310709 · Cited by 152
Self-citationAngiotensin II Activation of Cyclin D1-dependent Kinase Activity
Watanabe, G., Lee, R. J., Albanese, C., Rainey, W. E., BATLLE, D. C., & Pestell, R. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22570 · Cited by 145
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease
Torres, V. E., Donovan, K. A., Scicli, G. M., Holley, K. E., Thibodeau, S. N., Carretero, O. A., Inagami, T., McAteer, J. A., & Johnson, C. M. (1992) · Kidney International · doi:10.1038/ki.1992.297 · Cited by 138
Self-citationEpidemiological study of kidney survival in autosomal dominant polycystic kidney disease
Schrier, R. W., McFann, K. K., & Johnson, A. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00776.x · Cited by 136
Self-citationSpithoven, E. M., Kramer, A., Meijer, E., Ørskov, B., Wanner, C., Caskey, F. J., Collart, F., Finne, P., Fogarty, D. G., Groothoff, J. W., et al. (2014) · Kidney International · doi:10.1038/ki.2014.120 · Cited by 130
The anatomy of the renin-secreting cell in adult polycystic kidney disease
Graham, P., & Lindop, G. B. M. (1988) · Kidney International · doi:10.1038/ki.1988.115 · Cited by 121
Patch, C., Charlton, J., Roderick, P. J., & Gulliford, M. C. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.01.023 · Cited by 97
Introduction to Statistical Methods for Clinical Trials
Cook, T. D., & DeMets, D. L. (2007) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420009965 · Cited by 96
Analysis of baseline parameters in the HALT polycystic kidney disease trials
Torres, V. E., Chapman, A. B., Perrone, R. D., Bae, K. T., Abebe, K. Z., Bost, J. E., Miskulin, D. C., Steinman, T. I., Braun, W. E., Winklhofer, F. T., et al. (2011) · Kidney International · doi:10.1038/ki.2011.411 · Cited by 94
Self-citationTorres, V. E., Wilson, D. M., Burnett, J. C. J., JOHNSON, C. M., & Offord, K. P. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61724-8 · Cited by 74
Self-citationMRI-based Kidney Volume Measurements in ADPKD: Reliability and Effect of Gadolinium Enhancement
Bae, K. T., Tao, C., Zhu, F., Bost, J. E., Chapman, A. B., Grantham, J. J., Torres, V. E., Guay‐Woodford, L. M., Meyers, C. M., & Bennett, W. M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03750708 · Cited by 71
Self-citationØrskov, B., Sørensen, V. R., Feldt‐Rasmussen, B., & Strandgaard, S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr467 · Cited by 52
Reddy, P. K., P., R. K. B., Dhanalakshmi, P., Annigeri, R. A., Ramakrishnan, N., & Venkataraman, R. (2014) · Renal Failure · doi:10.3109/0886022x.2014.899432 · Cited by 14
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationTyson, C. C., & Coffman, T. M. (2017) · Nephron · doi:10.1159/000455130 · Cited by 710
Metadata
- Authors
- Schrier, R. W., Abebe, K. Z., Perrone, R. D., Torres, V. E., Braun, W. E., Steinman, T. I., Winklhofer, F. T., Brosnahan, G., Czarnecki, P. G., Hogan, M. C., Miskulin, D. C., Rahbari-Oskoui, F. F., Grantham, J. J., Harris, P. C., Flessner, M. F., Bae, K. T., Moore, C. G., & Chapman, A. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-12-11
- Volume
- 371
- Issue
- 24
- Pages
- 2255-2266
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1997286719
- Cited by
- 528
- References
- 30
- FWCI
- 33.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.